Page results
-
We run two separate Urogynaecology services at UCH: The Urogynaecology and Pelvic Floor Unit and The Female Pelvic Medicine and Reconstructive Surgery Unit.
-
At UCLH, we encourage self-referral to our antenatal service, but you also have the choice to go via your GP who will make the referral for you.
-
Our pain clinics are patient-centred and evidence-based, encouraging patients to self-manage their persistent facial pain.
-
This information is for children and young people with type 1 diabetes using a hybrid closed loop (HCL).
-
Patient information for patients suffering from long COVID who are returning to work.
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
The tissue viability team is committed to providing support, training and education to clinical staff, patients and carers about maintaining, promoting skin integrity and preventing pressure sores.
-
This patient information is intended to help patients suffering form long COVID to manage and understand their headaches.
-
For patients aged 13-18 we have a dedicated team covering a range of conditions, particularly specialising in reconstructive urology.
-
This page explains who you will meet and what to expect at your appointment with the adolescent gynaecology team at UCLH.
File results
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment
-
FOI/2024/0425 - Freedom of Information (FOI) structure, banding and job titles
-
FOI/2024/0426 - Agency staff spend for nursing, HCAs, pharmacists, occupational therapists and physiotherapists
-
FOI/2024/0439 - Digital dictation provider
-
FOI/2024/0455 - Information Governance structure
-
FOI/2024/0450 - Trust-wide obesity and weight management strategy
-
FOI/2024/0440 - Patient reported outcome measures (PROMs) in oncology
-
FOI/2024/0570 - Pathway for genetic/ genomic testing for MND